FBInvestor
Stocks / Aclaris Therapeutics Inc
Institutional Ownership

Aclaris Therapeutics Inc

CUSIP 00461U105COMACRSQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon